These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7781670

  • 1. CCK-A antagonists: which and how.
    D'Amato M, Rovati LC.
    Eur J Clin Invest; 1995 Mar; 25(3):213-4. PubMed ID: 7781670
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX.
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
    [Abstract] [Full Text] [Related]

  • 3. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
    [Abstract] [Full Text] [Related]

  • 4. CCK-8 contracts the gallbladder and colon through different mechanisms in the ferret.
    Mitan S, Greenwood B.
    Ann N Y Acad Sci; 1994 Mar 23; 713():401-3. PubMed ID: 8185202
    [No Abstract] [Full Text] [Related]

  • 5. [Cholecystokinin and its antagonists: effects on digestive motility].
    Bruley des Varannes S, Cloarec D, Dubois A, Galmiche JP.
    Gastroenterol Clin Biol; 1991 Mar 23; 15(10):744-57. PubMed ID: 1816015
    [No Abstract] [Full Text] [Related]

  • 6. Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors in the vagal pathway and gallbladder in the dog.
    Sonobe K, Sakai T, Satoh M, Haga N, Itoh Z.
    Regul Pept; 1995 Dec 07; 60(1):33-46. PubMed ID: 8747782
    [Abstract] [Full Text] [Related]

  • 7. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D, Gardner JD, Jensen RT, Maton PN.
    Am J Physiol; 1989 Jul 07; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
    Taniguchi H, Yazaki N, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 May 23; 304(1-3):147-54. PubMed ID: 8813597
    [Abstract] [Full Text] [Related]

  • 9. Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder.
    Grider JR, Makhlouf GM.
    Am J Physiol; 1990 Aug 23; 259(2 Pt 1):G184-90. PubMed ID: 2382717
    [Abstract] [Full Text] [Related]

  • 10. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.
    Clavé P, González A, Moreno A, López R, Farré A, Cussó X, D'Amato M, Azpiroz F, Lluís F.
    Gastroenterology; 1998 Sep 23; 115(3):597-604. PubMed ID: 9721157
    [Abstract] [Full Text] [Related]

  • 11. Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists.
    Kerwin JF, Nadzan AM, Kopecka H, Lin CW, Miller T, Witte D, Burt S.
    J Med Chem; 1989 Apr 23; 32(4):739-42. PubMed ID: 2704023
    [No Abstract] [Full Text] [Related]

  • 12. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1995 Jan 23; 114(2):339-48. PubMed ID: 7881733
    [Abstract] [Full Text] [Related]

  • 13. CCK/gastrin antagonists--clinical perspectives.
    Calam J.
    Acta Gastroenterol Belg; 1993 Jan 23; 56(3-4):251-6. PubMed ID: 8266765
    [Abstract] [Full Text] [Related]

  • 14. Effect of two new cholecystokinin antagonists on gallbladder emptying in opossums.
    Hanyu N, Dodds WJ, Layman RD, Hogan WJ, Colton DG.
    Am J Physiol; 1991 Feb 23; 260(2 Pt 1):G258-64. PubMed ID: 1996645
    [Abstract] [Full Text] [Related]

  • 15. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 23; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 16. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
    Xu MY, Yang DX, Wang SZ, Jin HB, Zou XH, Yang XP, Han JS.
    Sheng Li Xue Bao; 1998 Aug 23; 50(4):469-73. PubMed ID: 11324560
    [Abstract] [Full Text] [Related]

  • 17. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.
    D'Amato M, Stamford IF, Bennett A.
    Br J Pharmacol; 1991 Feb 23; 102(2):391-5. PubMed ID: 2015421
    [Abstract] [Full Text] [Related]

  • 18. Characterization of cholecystokinin receptors on the human gallbladder.
    Tokunaga Y, Cox KL, Coleman R, Concepcion W, Nakazato P, Esquivel CO.
    Surgery; 1993 Feb 23; 113(2):155-62. PubMed ID: 7679224
    [Abstract] [Full Text] [Related]

  • 19. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE, Creutzfeldt W, Höcker M, Choudhury AR, Nustede R, Schleser A, Nitsche R, Rovati LC, Schafmayer A, Fölsch UR.
    Digestion; 1990 Feb 23; 46 Suppl 2():232-9. PubMed ID: 2262057
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
    Taniguchi H, Yazaki N, Yomota E, Shikano T, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 Sep 26; 312(2):227-33. PubMed ID: 8894600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.